Search Results - "Tsygankova, O V"

Extended-release metformin in patients with prediabetes, chro­nic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters by Tsygankova, O. V., Apartseva, N. E., Latyntseva, L. D., Ryabikov, A. N.

“…BACKGROUND : Considering the role of visceral adipose tissue deposition in the pathogenesis of heart failure with preserved ejection fraction (HFpEF) and the…”
Get full text

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives by Tsygankova, O. V., Veretyuk, V. V.

“…The problems of heart failure (HF) are becoming increasingly important every year due to the increasing spread of cardiovascular diseases resulting in its…”
Get full text

Nonspecific aortoarteritis as a Cause of Aortic Dissection in a Middle Aged Man by Tsygankova, O. V., Bayramova, S. S., Akhmedzhanov, N. M.

“…Nonspecific aortoarteritis (Takayasu's disease) is a systemic inflammatory disease characterized by granulomatous lesions of the aorta and its large branches…”
Get full text

Statin-induced rhabdomyolysis in a 60-year-old woman with decompensated type 2 diabetes: a case report by Tsygankova, O. V., Evdokimova, N. E., Bayramova, S. S., Susekov, A. V.

“…Rhabdomyolysis is a very rare and most severe form of statin-induced muscle adverse event characterized by muscle pain, muscle necrosis with myoglobinemia…”
Get full text

Increment of the effectiveness of treating hypertension and dyslipidemia using a triple fixed-dose combination and the vascular age concept by Tsygankova, O. V., Batluk, T. I., Latyntseva, L. D.

“…Aim. To study the efficacy, safety and effect on vascular age of free-equivalent and fixed-dose combinations of amlodipine, a renin-angiotensin-aldosterone…”
Get full text

Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review) by Tsygankova, O. V., Timoshchenko, O. V., Tuzovskaya, O. V., Latyntseva, L. D., Nikolaev, K. Yu

“…Chronic heart failure is a global cardiac problem. The last decade can rightly be called a breakthrough in the treatment of this nosology, due to the emergence…”
Get full text

Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads by Tsygankova, O. V., Evdokimova, N. E., Veretyuk, V. V., Latyntseva, L. D., Ametov, A. S.

“…Insulin resistance, which is a fundamental pathogenetic factor of prediabetes, is closely associated with abdominal obesity on the one hand and the development…”
Get full text

Number of curves in the generalized Edwards form with minimal even cofactor of the curve order by Bessalov, A. V., Tsygankova, O. V.

“…We analyze properties of points of orders 2, 4, and 8 of a curve in the generalized Edwards form. Arithmetic for group operations with singular points of these…”
Get full text

Levels of marker lysosomal hydrolases in women with coronary heart disease depending on age and sex hormone level by Tsygankova, O. V., Evdokimova, N. E., Ragino, Yu. I., Latyntseva, L. D., Veretyuk, V. V., Starichkova, A. A.

“…Aim of the study was to evaluate the serum concentrations of three marker lysosomal hydrolases (cathepsin D, acid phosphatase (AP) and acid DNase (aDNAase)) in…”
Get full text

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use by Tsygankova, O. V., Latyntseva, L. D., Batluk, T. I., Platonov, D. Yu, Akhmedzhanov, N. M.

“…The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina…”
Get full text

SUCCESSFUL CORRECTION OF REFRACTORY ARTERIAL HYPERTENSION AND MORBID OBESITY IN PATIENT WITH SEVERE OBSTRUCTIVE APNEA SYNDROME by Tsygankova, O. V., Kalinina, E. M., Latyntseva, L. D., Voevoda, M. I.

Get full text

In the Refractory Hypertension “Labyrinth”. Focus on Primary Hyperaldosteronism by Tsygankova, O. V., Batluk, T. I., Latyntseva, L. D., Akhmerova, E. V., Akhmedzhanov, N. M.

“…Primary hyperaldosteronism is an existence of a functional autonomous source with increased aldosterone production (full or partial) in relation to the…”
Get full text

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris by Kashtalap, V. V., Barbarash, O. L., Sedykh, D. Yu, Krivoshapova, K. E., Tsygankova, D. P., Tsygankova, O. V.

“…Aim . To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB) in patients with stable angina, initially taking only BAB and…”
Get full text

ENDOTHELIUM-DEPENDENT VASCULAR REACTIVITY IN DIABETES MELLITUS TYPE 2 by Nikolaev, K Yu, Bairamova, S S, Tsygankova, O V, Lyfshits, G I

“…The review presents modern information on the development of disorders of endothelium-dependent vascular reactivity in diabetes mellitus (DM) type 2. In type 2…”
Get full text

Legal and Medical Aspects of Off-Label Medication Use. Point of View by Tsygankova, O. V., Batluk, T. I., Latyntseva, L. D., Platonov, D. Y., Akhmedzhanov, N. M.

“…The current state of the Russian and foreign regulatory framework for off-label prescription of medicines is presented in the article. The existing problems of…”
Get full text

Multifactorial Prognostication of Remote Outcomes in Patients With Non-ST Elevation Acute Coronary Syndrome by Tsygankova, V O, Lozhkina, G N, Khasanova, H M, Kuimov, D A, Ragino, I Y, Maksimov, N V, Voevoda, I M

“…Creation of a mathematical nonlinear regression model for prognostication of 1 year outcomes after non-ST elevation acute coronary syndrome (NSTE ACS) for…”
Get more information

DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE by Platonov, D. Yu, Kostjuk, T. A., Brandt, A. I., Tsygankova, O. V.

“…Aim. To analyze potential determinants of preventive behavior (PB) in patients with essential hypertension (HT) and chronic ischemic heart disease (CIHD), and…”
Get full text

How to descript a clinical case correctly: For inquiry scientists and demanding doctors by Tsygankova, O. V., Timoshchenko, O. V., Latyntseva, L. D.

“…The article presents step by step international CARE guidelines (CAse REport), which regulate the structure of the description of a clinical case and include a…”
Get full text

Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity by O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, Ya. V. Polonskaya, E. V. Kashtanova

“…Aim. To study the effect of extended-release (XR) metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with heart failure…”
Get full text

Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failure by Tsygankova, O. V., Apartseva, N. E., Latyntseva, L. D., Ryabikov, A. N., Kashtanova, E. V.

“…Introduction . Chronic heart failure with preserved ejection fraction (CHpEF) is a heterogeneous syndrome with a variety of pathophysiological factors,…”
Get full text